AI-generated summary
The authors studied whether light-activated TAPP, a cationic porphyrin photosensitizer, could boost antibiotics against Staphylococcus aureus and related bacteria in laboratory experiments. They report that illuminated TAPP's antibacterial activity was largely lost with a radical scavenger, that its effect was additive with chloramphenicol and tobramycin and synergistic against MRSA and S. epidermidis, and that toxicity to eukaryotic cells was dose-dependent.
- Who or what was studied
- Staphylococcus aureus, MRSA, Staphylococcus epidermidis, Escherichia coli and eukaryotic cells in vitro
- Limits stated in the abstract
- The study appears to be laboratory work on bacteria and cells rather than people, and the abstract does not report clinical outcomes.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photodynamic therapy, Dose. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.